MedTrace Logo

Effects of Doxycycline on Persistent Symptoms Post-neuroborreliosis

NCT01205464 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2010-09-20

No results posted yet for this study

Summary

The aim of this randomised, double-blind crossover study was to determine whether Doxycycline has an impact on the persistent symptoms post-neuroborreliosis, through alterations in the immune response and whether such an effect could influence the clinical outcome.

Conditions

  • Fatigue
  • Radicular Pain
  • Cognitive Dysfunction
  • Paresthesia
  • Paresis

Interventions

DRUG

Doxycycline

Doxycycline, 100 mg, 2 capsules once daily, 24 hour time interval, 21 days.

DRUG

Placebo

Placebo, 100 mg, 2 capsules once daily, 24 hour dosage interval, 21 days.

Sponsors & Collaborators

  • Linkoeping University

    lead OTHER_GOV

Principal Investigators

  • Pia Forsberg, MD · Department of Infectious Diseases, Faculty of Health Sciences, Linköping university, Sweden

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-02-28
Primary Completion
2008-02-29
Completion
2008-02-29

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01205464 on ClinicalTrials.gov